Showing 13 to 24 of 40 results
MHRA Investigates Link Between GLP-1 Drugs and Pancreatitis
The UK's MHRA is investigating a possible link between GLP-1 weight-loss drugs and pancreatitis, prompting a review of 560 cases, although current data doesn't indicate rates exceeding those in clinical trials; experts warn against unregulated use.
MHRA Investigates Link Between GLP-1 Drugs and Pancreatitis
The UK's MHRA is investigating a possible link between GLP-1 weight-loss drugs and pancreatitis, prompting a review of 560 cases, although current data doesn't indicate rates exceeding those in clinical trials; experts warn against unregulated use.
Progress
44% Bias Score
UK: Pregnancy Risk Linked to Weight-Loss Drugs and Birth Control Pills
In the UK, 40 women became pregnant while taking birth control pills and weight-loss drugs (Mounjaro, Saxenda, Ozempic/Wegovy); the MHRA warns of a potential link, advising against relying solely on oral contraceptives when using these drugs.
UK: Pregnancy Risk Linked to Weight-Loss Drugs and Birth Control Pills
In the UK, 40 women became pregnant while taking birth control pills and weight-loss drugs (Mounjaro, Saxenda, Ozempic/Wegovy); the MHRA warns of a potential link, advising against relying solely on oral contraceptives when using these drugs.
Progress
64% Bias Score
Mounjaro's "Golden Dose": Cost Savings vs. Deadly Risks
Due to high costs, Mounjaro users are extracting a "golden dose" from used pens, risking infections and overdoses; experts warn of potential pancreatitis and sepsis.
Mounjaro's "Golden Dose": Cost Savings vs. Deadly Risks
Due to high costs, Mounjaro users are extracting a "golden dose" from used pens, risking infections and overdoses; experts warn of potential pancreatitis and sepsis.
Progress
60% Bias Score
Weight-Loss Drugs Linked to Increased Osteoporosis Risk
Weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may cause significant bone and muscle loss, increasing osteoporosis risk, according to the Royal Osteoporosis Society. Up to 40 percent of weight loss from these drugs may come from bone and muscle, impacting approximately half a million users ...
Weight-Loss Drugs Linked to Increased Osteoporosis Risk
Weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may cause significant bone and muscle loss, increasing osteoporosis risk, according to the Royal Osteoporosis Society. Up to 40 percent of weight loss from these drugs may come from bone and muscle, impacting approximately half a million users ...
Progress
56% Bias Score
UK Obesity Crisis: Weight-Loss Drug Success Creates Dangerous Black Market
In the UK, the rising popularity of GLP-1 weight-loss medication like Wegovy and Ozempic, despite strict NHS access, has created a black market with reports of misuse leading to hospitalizations; while effective for weight loss and related health problems, unregulated access poses serious health ris...
UK Obesity Crisis: Weight-Loss Drug Success Creates Dangerous Black Market
In the UK, the rising popularity of GLP-1 weight-loss medication like Wegovy and Ozempic, despite strict NHS access, has created a black market with reports of misuse leading to hospitalizations; while effective for weight loss and related health problems, unregulated access poses serious health ris...
Progress
44% Bias Score
France Expands Access to Anti-Obesity Drugs
The French government will allow general practitioners to prescribe Wegovy and Mounjaro to combat obesity, affecting nearly 50% of French adults; a plan launching in September will address this through education, healthcare, sports, and medication, aiming to curb cardiovascular deaths.
France Expands Access to Anti-Obesity Drugs
The French government will allow general practitioners to prescribe Wegovy and Mounjaro to combat obesity, affecting nearly 50% of French adults; a plan launching in September will address this through education, healthcare, sports, and medication, aiming to curb cardiovascular deaths.
Progress
40% Bias Score
UK Weight-Loss Injections Linked to Pancreatitis Cases
Over a million people in the UK have used weight loss and diabetes jabs, with the Medicines and Healthcare products Regulatory Agency (MHRA) reporting 294 cases of pancreatitis (inflammation of the pancreas) linked to these drugs, including five deaths. A new study will investigate genetic links.
UK Weight-Loss Injections Linked to Pancreatitis Cases
Over a million people in the UK have used weight loss and diabetes jabs, with the Medicines and Healthcare products Regulatory Agency (MHRA) reporting 294 cases of pancreatitis (inflammation of the pancreas) linked to these drugs, including five deaths. A new study will investigate genetic links.
Progress
48% Bias Score
Weight-Loss Injections Pose Contraceptive Risks: Urgent MHRA Warning
The UK's MHRA issued an urgent warning that weight-loss injections, including Ozempic, Wegovy, and Mounjaro, may reduce contraceptive effectiveness and pose risks to pregnant women and fetuses, prompting advice on birth control and immediate cessation upon pregnancy.
Weight-Loss Injections Pose Contraceptive Risks: Urgent MHRA Warning
The UK's MHRA issued an urgent warning that weight-loss injections, including Ozempic, Wegovy, and Mounjaro, may reduce contraceptive effectiveness and pose risks to pregnant women and fetuses, prompting advice on birth control and immediate cessation upon pregnancy.
Progress
60% Bias Score
MHRA Warns of Pregnancy Risk with Weight-Loss Drugs
The UK's MHRA issued a warning about 40 reported pregnancies in women using weight-loss drugs like Ozempic, Wegovy, and Mounjaro, advising them to use effective contraception due to potential interactions and lack of safety data during pregnancy.
MHRA Warns of Pregnancy Risk with Weight-Loss Drugs
The UK's MHRA issued a warning about 40 reported pregnancies in women using weight-loss drugs like Ozempic, Wegovy, and Mounjaro, advising them to use effective contraception due to potential interactions and lack of safety data during pregnancy.
Progress
52% Bias Score
Mounjaro and Oral HRT: Increased Womb Cancer Risk
The British Menopause Society warns that women taking oral hormone replacement therapy (HRT) should consult their doctors before using the weight-loss jab Mounjaro, due to concerns about increased womb cancer risk because Mounjaro may reduce the absorption of oral progestogen, a component of HRT, po...
Mounjaro and Oral HRT: Increased Womb Cancer Risk
The British Menopause Society warns that women taking oral hormone replacement therapy (HRT) should consult their doctors before using the weight-loss jab Mounjaro, due to concerns about increased womb cancer risk because Mounjaro may reduce the absorption of oral progestogen, a component of HRT, po...
Progress
60% Bias Score
Australian Weight Loss Drug Users Report Liver Issues
Dozens of Australians using weight-loss injections Wegovy, Ozempic, and Mounjaro have reported liver problems, including hepatitis, prompting a warning from experts for regular GP check-ups; three cases linked to semaglutide were reported to the TGA.
Australian Weight Loss Drug Users Report Liver Issues
Dozens of Australians using weight-loss injections Wegovy, Ozempic, and Mounjaro have reported liver problems, including hepatitis, prompting a warning from experts for regular GP check-ups; three cases linked to semaglutide were reported to the TGA.
Progress
44% Bias Score
WeightWatchers Files for Bankruptcy Amidst Rise of Weight-Loss Injections
WeightWatchers filed for bankruptcy in the US due to $1.88 billion in liabilities exceeding asset value and decreased demand from the rise of weight loss injections, resulting in a $1.15 billion debt write-off while maintaining operations.
WeightWatchers Files for Bankruptcy Amidst Rise of Weight-Loss Injections
WeightWatchers filed for bankruptcy in the US due to $1.88 billion in liabilities exceeding asset value and decreased demand from the rise of weight loss injections, resulting in a $1.15 billion debt write-off while maintaining operations.
Progress
36% Bias Score
Showing 13 to 24 of 40 results